Analyst
HSBC
Equibles does not estimate personal net worth.
Damayan Dikirai is recorded as Analyst at HSBC. Damayan Dikirai has spoken on 1 earnings call across 1 company, most recently for Sun Pharmaceutical Industries Limited on May 22, 2026. The companies whose calls Damayan Dikirai spoke on are classified in the Healthcare sector.
“My question is regarding your EBITDA margin trajectory. So, you mentioned you will continue to invest in the new launches of AlexaV and AlexaV in the U.S., etc., and you have given R&D guidance.”
HSBC
Analyst
Transcript header (unverified)
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharma Q4 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
